PFA
PFE icon

Providence Financial Advisors’s Pfizer PFE Stock Holding History

Providence Financial Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$263K Hold
10,942
– – 0.15% 53
2026
Q1 		$307K Buy
10,942
+82
+0.8% +$2.18K 0.18% 40
2025
Q4 		$270K Sell
10,860
-197
-2% -$4.97K 0.27% 38
2025
Q3 		$282K Buy
+11,057
New +$273K 0.27% 38

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Providence Financial Advisors's PFE Position: Q2 2026 in Review

Providence Financial Advisors held its Pfizer (PFE) position steady in Q2 2026 at 10,942 shares worth $263K. The position accounts for 0.15% of the portfolio, ranked #53.

Providence Financial Advisors first reported a position in PFE in Q3 2025 and has held it in 4 quarters since. The position peaked at $307K in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Providence Financial Advisors held 10,942 shares of Pfizer worth $263K as of Q2 2026.
  • Providence Financial Advisors left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.15% of Providence Financial Advisors's portfolio in Q2 2026, its #53 holding.
  • Providence Financial Advisors first reported a position in Pfizer in Q3 2025 and has held it in 4 quarters since.
  • Providence Financial Advisors's Pfizer position peaked at $307K in Q1 2026.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Providence Financial Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.